PIONEER I: Paclitaxel Eluting Balloon and CoCr Stent on Paclitaxel Eluting Balloon safety and performance (First in human trial)

Trial Profile

PIONEER I: Paclitaxel Eluting Balloon and CoCr Stent on Paclitaxel Eluting Balloon safety and performance (First in human trial)

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 10 Oct 2011

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms PIONEER I
  • Most Recent Events

    • 10 Oct 2011 Status changed from recruiting to active, no longer recruiting, according to a Blue Medical media release.
    • 17 Nov 2010 New trial record
    • 15 Nov 2010 Blue Medicals' CoCr stent mounted on a Drug Eluting [paclitaxel] Balloon was given CE Mark approval based on preliminary data from this trial, according to a company issued media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top